Aske T. Iversen

Soborg, Denmark

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 16 publications

COVIDmeter - a questionnaire-based symptom monitoring system for the surveillance of COVID-19 in Denmark, 2020-2023.

COVIDmeter - a questionnaire-based symptom monitoring system for the surveillance of COVID-19 in Denmark, 2020-2023.

Journal: Epidemiology and infection

Published: October 22, 2025

The Underlying Causes of Secondary Bile Acid Diarrhea May Confound Cancer Risk.

The Underlying Causes of Secondary Bile Acid Diarrhea May Confound Cancer Risk.

Journal: The American journal of gastroenterology

Published: November 11, 2024

Effect of semaglutide 2.4 mg on use of antihypertensive and lipid-lowering treatment in five randomized controlled STEP trials.

Effect of semaglutide 2.4 mg on use of antihypertensive and lipid-lowering treatment in five randomized controlled STEP trials.

Journal: Obesity (Silver Spring, Md.)

Published: May 29, 2024

Risk of cancer in patients with bile acid diarrhoea: a Danish nationwide matched cohort study.

Risk of cancer in patients with bile acid diarrhoea: a Danish nationwide matched cohort study.

Journal: BMJ open gastroenterology

Published: January 04, 2024

Reducing BMI below the obesity threshold in adolescents treated with once-weekly subcutaneous semaglutide 2.4 mg.

Reducing BMI below the obesity threshold in adolescents treated with once-weekly subcutaneous semaglutide 2.4 mg.

Journal: Obesity (Silver Spring, Md.)

Published: March 30, 2023

Development of Inflammatory Bowel Disease in HIV Patients: A Danish Cohort Study (1983-2018) With American Validation (1999-2018).

Development of Inflammatory Bowel Disease in HIV Patients: A Danish Cohort Study (1983-2018) With American Validation (1999-2018).

Journal: Gastro hep advances

Published: December 19, 2022

Rectal Cancer Risk After Colectomy in Patients With Inflammatory Bowel Disease-A Population-Based Danish Cohort Study 1978-2018.

Rectal Cancer Risk After Colectomy in Patients With Inflammatory Bowel Disease-A Population-Based Danish Cohort Study 1978-2018.

Journal: Gastro hep advances

Published: November 30, 2022

Comparative Outcomes and Safety of Vedolizumab vs Tumor Necrosis Factor Antagonists for Older Adults With Inflammatory Bowel Diseases.

Comparative Outcomes and Safety of Vedolizumab vs Tumor Necrosis Factor Antagonists for Older Adults With Inflammatory Bowel Diseases.

Journal: JAMA network open

Published: September 30, 2022

The Risk of Type 2 Diabetes in Patients With Inflammatory Bowel Disease After Bowel Resections: A Nationwide Cohort Study.

The Risk of Type 2 Diabetes in Patients With Inflammatory Bowel Disease After Bowel Resections: A Nationwide Cohort Study.

Journal: Gastro hep advances

Published: September 19, 2022

Risk of anorectal cancer in patients with Crohn's disease and perianal fistula: a nationwide Danish cohort study.

Risk of anorectal cancer in patients with Crohn's disease and perianal fistula: a nationwide Danish cohort study.

Journal: Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland

Published: September 06, 2022

Early-Life Mebendazole Exposure Increases the Risk of Adult-Onset Ulcerative Colitis: A Population-Based Cohort Study.

Early-Life Mebendazole Exposure Increases the Risk of Adult-Onset Ulcerative Colitis: A Population-Based Cohort Study.

Journal: The American journal of gastroenterology

Published: August 30, 2022

Antibiotic use as a risk factor for inflammatory bowel disease across the ages: a population-based cohort study.

Antibiotic use as a risk factor for inflammatory bowel disease across the ages: a population-based cohort study.

Journal: Gut

Published: May 25, 2022

Showing 1-12 of 16

Last Updated: 09/26/2026